Royal Bank of Canada’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,486
| Closed | -$2K | – | 7089 |
|
|
2025
Q2 | $2K | Buy |
1,486
+475
| +47% | +$571 | ﹤0.01% | 6773 |
|
|
2025
Q1 | $1K | Sell |
1,011
-787
| -44% | -$1.72K | ﹤0.01% | 6619 |
|
|
2024
Q4 | $4K | Sell |
1,798
-1,421
| -44% | -$3.76K | ﹤0.01% | 6565 |
|
|
2024
Q3 | $9K | Buy |
3,219
+420
| +15% | +$1.03K | ﹤0.01% | 6353 |
|
|
2024
Q2 | $7K | Buy |
2,799
+1,758
| +169% | +$5.61K | ﹤0.01% | 6434 |
|
|
2024
Q1 | $4K | Sell |
1,041
-7,022
| -87% | -$36.5K | ﹤0.01% | 6477 |
|
|
2023
Q4 | $39K | Buy |
8,063
+4,906
| +155% | +$20.4K | ﹤0.01% | 6092 |
|
|
2023
Q3 | $14K | Buy |
3,157
+1,724
| +120% | +$9.91K | ﹤0.01% | 6300 |
|
|
2023
Q2 | $10K | Buy |
1,433
+216
| +18% | +$1.44K | ﹤0.01% | 6463 |
|
|
2023
Q1 | $9K | Sell |
1,217
-1,277
| -51% | -$13.3K | ﹤0.01% | 6351 |
|
|
2022
Q4 | $24K | Buy |
2,494
+1,972
| +378% | +$24.3K | ﹤0.01% | 6226 |
|
|
2022
Q3 | $6K | Buy |
522
+103
| +25% | +$1.36K | ﹤0.01% | 6640 |
|
|
2022
Q2 | $5K | Sell |
419
-735
| -64% | -$7.62K | ﹤0.01% | 6627 |
|
|
2022
Q1 | $12K | Sell |
1,154
-1,619
| -58% | -$18.8K | ﹤0.01% | 6869 |
|
|
2021
Q4 | $42K | Buy |
2,773
+1,709
| +161% | +$22.4K | ﹤0.01% | 6463 |
|
|
2021
Q3 | $14K | Buy |
1,064
+541
| +103% | +$9.04K | ﹤0.01% | 6829 |
|
|
2021
Q2 | $10K | Buy |
+523
| New | +$10.8K | ﹤0.01% | 6862 |
|
Royal Bank of Canada's AKYA Position: Q3 2025 in Review
Royal Bank of Canada sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 1,486 shares — an estimated $2K sold.
Royal Bank of Canada first reported a position in AKYA in Q2 2021 and held it in 17 quarters. The position peaked at $42K in Q4 2021. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.
- Royal Bank of Canada reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
- Royal Bank of Canada sold 1,486 Akoya BioSciences shares in Q3 2025, an estimated $2K.
- Royal Bank of Canada first reported a position in Akoya BioSciences in Q2 2021 and held it in 17 quarters.
- Royal Bank of Canada's Akoya BioSciences position peaked at $42K in Q4 2021.
- 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.
Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.